The first study, published in the International Journal for Research in Applied and Natural Science, examined the role of its Ashwadaat-branded ashwagandha ingredient for stress management and sleep improvements.
Data from an open-label, multi-center, human clinical trial indicated that a 1 gram per day dose of the Ashwadaat led to significant improvements in Perceived Stress Scale (PSS) scores and a 55% improvement in Insomnia Severity Index scores.
Improvements in measures of quality of life (QoL) were also observed in the study, which lasted for 30 days and included 30 people aged between 18 and 55.
The India-based scientists concluded: “The present study concludes that Ashwadaat helps in reduction of stress and other associated symptom, also effective in improving sleep quality. The product was also found to be safe without producing any adverse effects. Further comparative studies with larger sample size are warranted to validate and confirm on the clinical efficacy as well as mode of action of Ashwadaat.”
Holy Basil
A second study, also published in the International Journal for Research in Applied and Natural Science, examined the potential efficacy of the company’s Holy Basil-based ingredient, which is branded TulsiOdaat.
The scientists recruited 31 people with mild-to-moderate insomnia to participate in their open label, single arm, multi-centric study. The participants received 450 mg TulsiOdaat twice a day for 30 days with the results indicating improvements in scores for total sleep time and sleep efficiency.
Lodaat build science for ingredient portfolio with new studies - NutraIngredients-usa.com
Read More
No comments:
Post a Comment